
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The role of gut microbiota in gout: Is gut microbiota a potential target for gout treatment
Shuting Tong, Peiyu Zhang, Qi Cheng, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 28
Shuting Tong, Peiyu Zhang, Qi Cheng, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 28
Showing 1-25 of 28 citing articles:
Role of NLRP3 in the pathogenesis and treatment of gout arthritis
Yaru Liu, Jiequan Wang, Jun Li
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 64
Yaru Liu, Jiequan Wang, Jun Li
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 64
The microbiota–gut–brain axis in Huntington's disease: pathogenic mechanisms and therapeutic targets
Millicent N. Ekwudo, Carolina Gubert, Anthony J. Hannan
FEBS Journal (2024)
Open Access | Times Cited: 18
Millicent N. Ekwudo, Carolina Gubert, Anthony J. Hannan
FEBS Journal (2024)
Open Access | Times Cited: 18
Exploring the gut microbiota: lifestyle choices, disease associations, and personal genomics
Sharlize Pedroza Matute, Sasitaran Iyavoo
Frontiers in Nutrition (2023) Vol. 10
Open Access | Times Cited: 38
Sharlize Pedroza Matute, Sasitaran Iyavoo
Frontiers in Nutrition (2023) Vol. 10
Open Access | Times Cited: 38
Emerging Urate-Lowering Drugs and Pharmacologic Treatment Strategies for Gout: A Narrative Review
Robert Terkeltaub
Drugs (2023) Vol. 83, Iss. 16, pp. 1501-1521
Closed Access | Times Cited: 32
Robert Terkeltaub
Drugs (2023) Vol. 83, Iss. 16, pp. 1501-1521
Closed Access | Times Cited: 32
Dissecting the causal effect between gut microbiota, DHA, and urate metabolism: A large-scale bidirectional Mendelian randomization
Tianzhichao Hou, Huajie Dai, Qi Wang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 18
Tianzhichao Hou, Huajie Dai, Qi Wang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 18
Gut microbiota mediated the therapeutic efficiency of Simiao decoction in the treatment of gout arthritis mice
Xiaoying Lin, Mingzhu Wang, Zhixing He, et al.
BMC Complementary Medicine and Therapies (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 13
Xiaoying Lin, Mingzhu Wang, Zhixing He, et al.
BMC Complementary Medicine and Therapies (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 13
Alteration of gut microbiome in goslings infected with goose astrovirus
Haiqin Li, Qi Su, Duanfeng Fu, et al.
Poultry Science (2024) Vol. 103, Iss. 8, pp. 103869-103869
Open Access | Times Cited: 5
Haiqin Li, Qi Su, Duanfeng Fu, et al.
Poultry Science (2024) Vol. 103, Iss. 8, pp. 103869-103869
Open Access | Times Cited: 5
Assessing the causal relationships of gut microbial genera with hyperuricemia and gout using two-sample Mendelian randomization
Yu Lou, Bin Liu, Zhounan Jiang, et al.
Nutrition Metabolism and Cardiovascular Diseases (2024) Vol. 34, Iss. 4, pp. 1028-1035
Closed Access | Times Cited: 4
Yu Lou, Bin Liu, Zhounan Jiang, et al.
Nutrition Metabolism and Cardiovascular Diseases (2024) Vol. 34, Iss. 4, pp. 1028-1035
Closed Access | Times Cited: 4
Gut-immunity-joint axis: a new therapeutic target for gouty arthritis
Pei‐Jer Chen, Zhiqiang Luo, Chengyin Lu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 4
Pei‐Jer Chen, Zhiqiang Luo, Chengyin Lu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 4
Mechanisms Associated With Renal Injury in Hyperuricemia and Strategies for the Development of Natural Active Substances
Wanping Lv, Huixiang Chen, Pan Zhou, et al.
International Journal of Rheumatic Diseases (2025) Vol. 28, Iss. 2
Closed Access
Wanping Lv, Huixiang Chen, Pan Zhou, et al.
International Journal of Rheumatic Diseases (2025) Vol. 28, Iss. 2
Closed Access
Metatranscriptomic analysis reveals gut microbiome bacterial genes in pyruvate and amino acid metabolism associated with hyperuricemia and gout in humans
Gabriela Angélica Martínez‐Nava, Efren Altamirano-Molina, Janitzia Vázquez‐Mellado, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Gabriela Angélica Martínez‐Nava, Efren Altamirano-Molina, Janitzia Vázquez‐Mellado, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Untargeted Metabolomics and Network Pharmacology Reveal the Uric Acid-Lowering Effects of Alcohol Extract of Gnaphalium affine and Its Extracts in Hyperuricemic Rats
Chen Wang, Xinchao He, L. Venkateswar Rao, et al.
Food Bioscience (2025), pp. 106471-106471
Closed Access
Chen Wang, Xinchao He, L. Venkateswar Rao, et al.
Food Bioscience (2025), pp. 106471-106471
Closed Access
Uric Acid-Degrading Lacticaseibacillus paracasei CPU202306 Ameliorates Hyperuricemia by Regulating Uric Acid Metabolism and Intestinal Microecology in Mice
Shuang Zhou, Xin Wen, Duncan James Lessing, et al.
Probiotics and Antimicrobial Proteins (2025)
Closed Access
Shuang Zhou, Xin Wen, Duncan James Lessing, et al.
Probiotics and Antimicrobial Proteins (2025)
Closed Access
Metagenome‐Based Characterization of the Gut Virome Signatures in Patients With Gout
Liansha Huang, Changming Chen, Jinxin Meng, et al.
Journal of Medical Virology (2025) Vol. 97, Iss. 4
Closed Access
Liansha Huang, Changming Chen, Jinxin Meng, et al.
Journal of Medical Virology (2025) Vol. 97, Iss. 4
Closed Access
Baseline gut microbiome as a predictive biomarker of response to probiotic adjuvant treatment in gout management
Feiyan Zhao, Ning Tie, Lai‐Yu Kwok, et al.
Pharmacological Research (2024) Vol. 209, pp. 107445-107445
Open Access | Times Cited: 3
Feiyan Zhao, Ning Tie, Lai‐Yu Kwok, et al.
Pharmacological Research (2024) Vol. 209, pp. 107445-107445
Open Access | Times Cited: 3
Causal Relationship between Gut Microbiota and Gout: A Two-Sample Mendelian Randomization Study
Mengna Wang, Jiayao Fan, Zhaohui Huang, et al.
Nutrients (2023) Vol. 15, Iss. 19, pp. 4260-4260
Open Access | Times Cited: 8
Mengna Wang, Jiayao Fan, Zhaohui Huang, et al.
Nutrients (2023) Vol. 15, Iss. 19, pp. 4260-4260
Open Access | Times Cited: 8
Disproportionately higher cardiovascular disease risk and incidence with high fructose corn syrup sweetened beverage intake among black young adults–the CARDIA study
Luanne Robalo DeChristopher, Katherine L. Tucker
Nutrition Journal (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 2
Luanne Robalo DeChristopher, Katherine L. Tucker
Nutrition Journal (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 2
Adherence to Healthy and Unhealthy Plant-Based Diets and the Risk of Gout
K. Sharan, Siyue Wang, Yang Hu, et al.
JAMA Network Open (2024) Vol. 7, Iss. 5, pp. e2411707-e2411707
Open Access | Times Cited: 2
K. Sharan, Siyue Wang, Yang Hu, et al.
JAMA Network Open (2024) Vol. 7, Iss. 5, pp. e2411707-e2411707
Open Access | Times Cited: 2
Wild-type Escherichia coli Nissle 1917 improves hyperuricemia by anaerobically degrading uric acid and maintaining gut microbiota profile of mice
Yanmei Sun, Dongmei Xu, Guangming Zhang, et al.
Journal of Functional Foods (2023) Vol. 112, pp. 105935-105935
Open Access | Times Cited: 4
Yanmei Sun, Dongmei Xu, Guangming Zhang, et al.
Journal of Functional Foods (2023) Vol. 112, pp. 105935-105935
Open Access | Times Cited: 4
Association between Gout and Gastric Cancer: A Nested Case–Control Study Using a National Health Sample Cohort
Mi Jung Kwon, Kyeong Min Han, Ji Hee Kim, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 3, pp. 229-229
Open Access | Times Cited: 1
Mi Jung Kwon, Kyeong Min Han, Ji Hee Kim, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 3, pp. 229-229
Open Access | Times Cited: 1
Reassessing Gout Management through the Lens of Gut Microbiota
Jean Demarquoy, Oumaima Dehmej
Applied Microbiology (2024) Vol. 4, Iss. 2, pp. 824-838
Open Access | Times Cited: 1
Jean Demarquoy, Oumaima Dehmej
Applied Microbiology (2024) Vol. 4, Iss. 2, pp. 824-838
Open Access | Times Cited: 1
Integrated Analysis of Microbiome and Metabolome Reveals Disease-Specific Profiles in Inflammatory Bowel Diseases and Intestinal Behçet’s Disease
Yehyun Park, Jae Bum Ahn, Da Hye Kim, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6697-6697
Open Access | Times Cited: 1
Yehyun Park, Jae Bum Ahn, Da Hye Kim, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6697-6697
Open Access | Times Cited: 1
Experimental and computational models to investigate intestinal drug permeability and metabolism
Jin-Yuan Chen, Ziyun Yuan, Yifan Tu, et al.
Xenobiotica (2023) Vol. 53, Iss. 1, pp. 25-45
Closed Access | Times Cited: 2
Jin-Yuan Chen, Ziyun Yuan, Yifan Tu, et al.
Xenobiotica (2023) Vol. 53, Iss. 1, pp. 25-45
Closed Access | Times Cited: 2
Gut Microbiota’s role in lipoma development: evidence from mendelian randomization
Yuxin Li, Jiahao Chen, Hang Yao, et al.
Frontiers in Genetics (2024) Vol. 15
Open Access
Yuxin Li, Jiahao Chen, Hang Yao, et al.
Frontiers in Genetics (2024) Vol. 15
Open Access
Research hotspots and trends related to pain in gouty arthritis from 2014 to 2024: A bibliometric analysis
Chengyin Lu, Yuxing Guo, Zhiqiang Luo, et al.
Medicine (2024) Vol. 103, Iss. 46, pp. e40525-e40525
Open Access
Chengyin Lu, Yuxing Guo, Zhiqiang Luo, et al.
Medicine (2024) Vol. 103, Iss. 46, pp. e40525-e40525
Open Access